AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Rutlandherald

Published November 12, 2026

Beond to Provide ARPA-H Clinical Safety Data From 250 Ibogaine Patients as ... - Rutland Herald

Read the full story at Rutlandherald

The ibogaine Beond uses is supported by certificates of analysis. Beond's board-certified physicians, including a licensed psychiatrist, review every.

Post on X

Share this story

Surfaced by this Google Alert

Ibogaine